Cover Image

Biobanking in times of crisis: the COVID-19 Autopsy and Biosample Registry Baden-Wuerttemberg

Biobanking plays a critical role in diagnostics, biomarker research and development of novel treatment approaches for various diseases. In urgent need of understanding, preventing and treating coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus-2 (SARS-Co...

Full description

Saved in:
Bibliographic Details
Main Authors: Domke, Lisa Maria (Author) , Klein, Isabel M. (Author) , Hartmann, Laura (Author) , Schwab, Constantin (Author) , Marx, Alexander (Author) , Werner, Martin (Author) , Möller, Peter (Author) , Fend, Falko (Author) , Bösmüller, Hans (Author) , Schirmacher, Peter (Author)
Format: Article (Journal)
Language:English
Published: [September 2022]
In: Pathology, research and practice
Year: 2022, Volume: 237, Pages: 1-5
ISSN:1618-0631
DOI:10.1016/j.prp.2022.154011
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.prp.2022.154011
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S0344033822002552
Get full text
Author Notes:Lisa M. Domke, Isabel M. Klein, Laura Hartmann, Constantin Schwab, Alexander Marx, Martin Werner, Peter Möller, Falko Fend, Hans Bösmüller, Peter Schirmacher
Description
Summary:Biobanking plays a critical role in diagnostics, biomarker research and development of novel treatment approaches for various diseases. In urgent need of understanding, preventing and treating coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the importance of biobanking including data sharing and management further increased. To provide high quality tissue biomaterials and data for research and public health, the COVID-19 Autopsy and Biosample Registry was established in the state of Baden-Wuerttemberg (BW) in Germany, combining expertise and technologies of the Institutes of Pathology of the five university hospitals in BW (Heidelberg, Tübingen, Ulm, Freiburg, Mannheim). The COVID-19 Autopsy and Biosample Registry BW comprises tissue samples from autopsies and associated data of deceased patients in the context of SARS-CoV-2 infection and/or vaccination against SARS-CoV-2. The aim is to collect autopsy biospecimens, associated clinical and diagnostic data in a timely manner, register them, make them accessible for research projects and thus to support especially tissue-related research addressing COVID-19. By now, the BW network holds multiple collaborations and supported numerous publications to increase the understanding of COVID-19 disease. The achievements of the BW network as a landmark biobanking model project represent a potential blueprint for future disease-related biobanking and registry effort.
Item Description:Gesehen am 27.10.2022
Physical Description:Online Resource
ISSN:1618-0631
DOI:10.1016/j.prp.2022.154011

Similar Items